Transgenomic, Inc. (TBIO) - Product Pipeline Analysis

GlobalData, August 2012, Pages: 33

Transgenomic, Inc. (TBIO) - Product Pipeline Analysis

Summary

Transgenomic, Inc. (Transgenomic) is a biotechnology company, based in the US. It provides products and services for automated high sensitivity genetic variation and mutation analysis. The company offers systems products, discovery and laboratory testing services to the academic and medical research, clinical laboratory and pharmaceutical market. Its products include consumables, navigator software, surveyor nuclease kits, surveyor scan mutation detection kits, Mito screen assay kit and other products. Transgenomic’s consumable product manufacturing, distribution and instrument support services is certified by an ISO 9001:2008. The company was incorporated in 1997. Transgenomic is headquartered in Omaha, Nebraska, the US.

This report is a source for data, analysis and actionable intelligence on the Transgenomic, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

List of Tables
List of Figures
Key Facts
Transgenomic, Inc. - Major Products and Services
Transgenomic, Inc. Pipeline Products by Equipment Type
Transgenomic, Inc. Pipeline Products by Development Stage
Transgenomic, Inc. Pipeline Products by Therapy Area
Transgenomic, Inc. Pipeline Products by Milestone Summary
BLOCker - Sequencing Assay
BLOCker - Sequencing Assay Product Status
BLOCker - Sequencing Assay Product Description
BLOCker - Sequencing Assay Product Milestone
COLD-PCR Assay - Colorectal Cancer
COLD-PCR Assay - Colorectal Cancer Product Status
COLD-PCR Assay - Colorectal Cancer Product Description
COLD-PCR Assay - Lung Cancer
COLD-PCR Assay - Lung Cancer Product Status
COLD-PCR Assay - Lung Cancer Product Description
Ice COLD-PCR And BLOCker-Sequencing Combination Kit
Ice COLD-PCR And BLOCker-Sequencing Combination Kit Product Status
Ice COLD-PCR And BLOCker-Sequencing Combination Kit Product Description
NRAS Cancer Genetic Marker Test
NRAS Cancer Genetic Marker Test Product Status
NRAS Cancer Genetic Marker Test Product Description
PIK3CA Cancer Genetic Marker Test
PIK3CA Cancer Genetic Marker Test Product Status
PIK3CA Cancer Genetic Marker Test Product Description
SURVEYOR Scan - BRAF
SURVEYOR Scan - BRAF Product Status
SURVEYOR Scan - BRAF Product Description
TP53 Cancer Genetic Marker Test
TP53 Cancer Genetic Marker Test Product Status
TP53 Cancer Genetic Marker Test Product Description
Transgenomic, Inc. - Key Competitors
Transgenomic, Inc. - Key Employees
Transgenomic, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Transgenomic, Inc., Recent Developments
Aug 01, 2012: Transgenomic Reports Revenue Of $9.1m In Q2 2012
Jun 11, 2012: USPTO Issues PIK3CA Gene Patent For Predicting Response To Targeted Therapy
May 08, 2012: Transgenomic Reports Net Sales Of $7.2m In Q1 2012
Mar 20, 2012: Transgenomic And MD Anderson Collaborate On Circulating Tumor Cell Study Using ICE COLD-PCR
Mar 07, 2012: Transgenomic Reports Net Sales Of $8.6m In Q4 2011
Jan 09, 2012: Transgenomic And Power3 Medical Resolve All Outstanding Litigation Proceedings And Disputes
Nov 14, 2011: Transgenomic Launches Two Genetic Tests At Annual American Heart Association Meeting
Nov 09, 2011: Transgenomic Reports Net Sales Of $8.3m In Q3 2011
Aug 11, 2011: Transgenomic Reports Total Sales Of $7.7m In Q2 2011
May 12, 2011: Transgenomic Reports Net Loss Of $3m For Q1 2011
Appendix
Methodology
About Us
Contact Us
Disclaimer

List of Tables
Transgenomic, Inc., Key Facts
Transgenomic, Inc. Key Pipeline Products by Equipment Type
Transgenomic, Inc. Key Pipeline Products by Therapy Area
Transgenomic, Inc. Key Pipeline Products by Development Stage
Transgenomic, Inc., Key Facts
Transgenomic, Inc., Major Products and Services
Transgenomic, Inc. Number of Pipeline Products by Equipment Type
Transgenomic, Inc. Pipeline Products by Equipment Type
Transgenomic, Inc. Number of Pipeline Products by Development Stage
Transgenomic, Inc. Pipeline Products by Development Stage
Transgenomic, Inc. Number of Pipeline Products by Therapy Area
Transgenomic, Inc. Pipeline Products by Therapy Area
Transgenomic, Inc. Number of Pipeline Products By Milestone Summary
Transgenomic, Inc. Pipeline Products by Milestone Summary
BLOCker - Sequencing Assay - Product Status
BLOCker - Sequencing Assay - Product Description
BLOCker - Sequencing Assay - Product Milestone
COLD-PCR Assay - Colorectal Cancer - Product Status
COLD-PCR Assay - Colorectal Cancer - Product Description
COLD-PCR Assay - Lung Cancer - Product Status
COLD-PCR Assay - Lung Cancer - Product Description
Ice COLD-PCR And BLOCker-Sequencing Combination Kit - Product Status
Ice COLD-PCR And BLOCker-Sequencing Combination Kit - Product Description
NRAS Cancer Genetic Marker Test - Product Status
NRAS Cancer Genetic Marker Test - Product Description
PIK3CA Cancer Genetic Marker Test - Product Status
PIK3CA Cancer Genetic Marker Test - Product Description
SURVEYOR Scan - BRAF - Product Status
SURVEYOR Scan - BRAF - Product Description
TP53 Cancer Genetic Marker Test - Product Status
TP53 Cancer Genetic Marker Test - Product Description
Transgenomic, Inc., Key Employees
Transgenomic, Inc., Other Locations

List of Figures
Transgenomic, Inc. Pipeline Products by Equipment Type
Transgenomic, Inc. Pipeline Products by Development Stage
Transgenomic, Inc. Pipeline Products by Therapy Area
Transgenomic, Inc. Pipeline Products by Milestone Summary

Covenant Health
Protedyne, Inc.
NeoGenomics, Inc.
American Bionostica, Inc.
Quidel Corporation

Customers who bought this item also bought

• Top Five Global Electric Vehicle Companies: Performance, Strategies and Competitive Analysis
• Supplying Ford 2012
• Supplying Chrysler
• Ford Motor Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Global Automotive Head-up Display Market 2012-2016
• General Motors Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• American Tire Distributors Holdings, Inc. - Strategic SWOT Analysis Review
• Global Friction Products Market 2012-2016
• Supplying the Volkswagen Group
• American Axle & Manufacturing Holdings, Inc. (AXL) - Financial and Strategic SWOT Analysis Review